title: Gonorrhea treatment guidelines in Canada: 2004 update.
authors.affiliation: Public Health Agency of Canada, Ottawa, Ont.
authors.forename: Janice
authors.initials: J
authors.lastname: Mann
authors.forename: Rhonda
authors.initials: R
authors.lastname: Kropp
authors.forename: Tom
authors.initials: T
authors.lastname: Wong
authors.forename: Sylvie
authors.initials: S
authors.lastname: Venne
authors.forename: Barbara
authors.initials: B
authors.lastname: Romanowski
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D002170:Canada; D002511:Cephalosporins / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D024841:Fluoroquinolones / Q000494:pharmacology / Q000627:therapeutic use*; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D000198:Spectinomycin / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D002511:Cephalosporins; D024841:Fluoroquinolones; D017963:Azithromycin; D000198:Spectinomycin